TY - JOUR T1 - The role of gender within the "stop smoking" program JF - European Respiratory Journal JO - Eur Respir J VL - 40 IS - Suppl 56 SP - P4041 AU - Manuela Stoleru Y1 - 2012/09/01 UR - http://erj.ersjournals.com/content/40/Suppl_56/P4041.abstract N2 - IntroductionUnderstanding individual differences in smoking behavior and addiction to nicotine can increase knowledge in the development of therapy, influence the outcomes of treatment and is a challenge for developers.ObjectiveThe purpose of our study was to evaluate the role of sex in the effectiveness of smoking cessation to the National Romanian Program.Methods and materialIt is a study of a sample of 306 smokers from 01/07/2008 to 31/12/2009 interested to stop smoking. They were assessed on the age, sex, domicile, the level of CO expire, test Fagerstrom, the family situation, the type of tobacco and the amount for a maximum period of 12 weeks. First line treatments include Nicotinic substitutes, the bupropion and varenicline.ResultsWe evaluate 216 (70.58 %) male, the average age was 43.72 years SD 13.5 95% CI 41 92-45. 53, smoking 30.90 PA comparative with 91 of women age 40.53 average SD 11.8 95% CI-38.06 43.01 who smoke 15.66 PA medium, SD 11.9 95% CI = 14 87 - 19.64. Men also started smoking earlier and had high dependence on nicotine than women. There is not a clear difference in the Fagerstrom test: TF = 5.85 for women TF = 5.62 for man.The costs were almost equally distributed between the two categories.There are no significant differences in looking at marital status: 76.92% comparative married women with 77.77% men. In both categories, the therapeutic attitude is dominated by the Champix 65.93% men to 51.38 % women. At the end of the treatment, were abstinent 40.65% women and 47.68% men.ConclusionSex does not appear to be a predictive factor of cessation in treated individuals persons. Analyses of individual differences should focus on the identification of the processes that control the smoking behavior. ER -